Insider · CIK 0001343811

Provencio Norma Ann

CIK 0001343811 Name as filed on the most recent filing

Filed as Provencio Norma Ann (20)

29 transaction lines · from 20 filings · filed 2009-03-02 to 2025-02-10 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

29 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2025-02-10 P, Open-market purchase Beazer Homes USA IncBZH 109,650, acquired Open Form 4 filing 0000915840-25-000028
2014-08-01 P, Open-market purchase Beazer Homes USA IncBZH 48,768, acquired Open Form 4 filing 0001179110-14-012288
2014-04-01 S, Open-market sale Valeant Pharmaceuticals International, Inc.VRX 660,886, disposed Open Form 4 filing 0000885590-14-000033
2014-03-03 S, Open-market sale Valeant Pharmaceuticals International, Inc.VRX 708,076, disposed Open Form 4 filing 0000885590-14-000026
2014-02-03 S, Open-market sale Valeant Pharmaceuticals International, Inc.VRX 681,158, disposed Open Form 4 filing 0000885590-14-000017
2014-01-13 S, Open-market sale Valeant Pharmaceuticals International, Inc.VRX 664,997, disposed Open Form 4 filing 0000885590-14-000009
2013-11-01 S, Open-market sale Valeant Pharmaceuticals International, Inc.VRX 533,486, disposed Open Form 4 filing 0000885590-13-000096
2013-09-06 S, Open-market sale Valeant Pharmaceuticals International, Inc.VRX 401,000, disposed Open Form 4 filing 0000885590-13-000081
2013-09-03 S, Open-market sale Valeant Pharmaceuticals International, Inc.VRX 498,400, disposed Open Form 4 filing 0000885590-13-000080
2013-06-11 S, Open-market sale Valeant Pharmaceuticals International, Inc.VRX 511,557, disposed Open Form 4 filing 0000885590-13-000050
2012-11-14 P, Open-market purchase Beazer Homes USA IncBZH Not reported Open Form 4 filing 0001179110-12-016185
2012-05-22 P, Open-market purchase Valeant Pharmaceuticals International, Inc.VRX 3 lines 201,714, acquired Open Form 4 filing 0000885590-12-000033
2011-11-22 P, Open-market purchase Beazer Homes USA IncBZH 25,610, acquired Open Form 4 filing 0001179110-11-015561
2011-08-09 P, Open-market purchase Valeant Pharmaceuticals International, Inc.VRX 2 lines 92,154, acquired Open Form 4 filing 0000885590-11-000055
2011-05-16 P, Open-market purchase Valeant Pharmaceuticals International, Inc.VRX 49,850, acquired Open Form 4 filing 0000885590-11-000026
2011-05-13 P, Open-market purchase Valeant Pharmaceuticals International, Inc.VRX 51,240, acquired Open Form 4 filing 0000885590-11-000026
2011-03-04 P, Open-market purchase Valeant Pharmaceuticals International, Inc.VRX 3 lines 62,801, acquired Open Form 4 filing 0000885590-11-000019
2011-03-04 P, Open-market purchase Valeant Pharmaceuticals International, Inc.VRX 3 lines 62,801, acquired Open Form 4 filing 0000885590-11-000010
2010-11-10 P, Open-market purchase Valeant Pharmaceuticals International, Inc.VRX 2 lines 123,750, acquired Open Form 4 filing 0000885590-11-000018
2009-11-12 P, Open-market purchase Valeant Pharmaceuticals InternationalVRX 33,250, acquired Open Form 4 filing 0001209499-09-000101
2009-02-26 P, Open-market purchase Valeant Pharmaceuticals InternationalVRX 44,364, acquired Open Form 4 filing 0001209500-09-000028

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 21
  • Open-market sale 8
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Provencio Norma Ann, insider transactions. Retrieved 2026-08-23 from https://ebomi.com/insider/0001343811

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.